NCT02097784

Brief Summary

This prospective study focuses on the interest of the echocardiography for cirrhotic patients, who present acute kidney injury corresponding to the criteria of hepatorenal syndrome. This echocardiography will be done before the volemic expansion and the final diagnostic of hepatorenal syndrome or prerenal azotemia. The primary endpoint is to describe the hemodynamic characteristics of this population at the time of acute kidney injury and their association with diagnostic of hepatorenal syndrome or prerenal azotemia. Patients with elevated filling pressure, predicting poor outcome of volemic expansion will be excluded of the study after the echocardiography and will not undergo volemic expansion but appropriate management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

March 24, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 27, 2014

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

4.3 years

First QC Date

March 24, 2014

Last Update Submit

December 13, 2025

Conditions

Keywords

cirrhosishepatorenal syndromeacute kidney injurydiastolic function

Outcome Measures

Primary Outcomes (1)

  • Hemodynamic features assessed by echocardiography before the volemic expansion of cirrhotic patients with acute renal injury corresponding to the criteria of hepatorenal syndrome.

    Systolic and diastolic function assessment, filling pressures, pulmonary arterial hypertension

    At Day0 : at the time of diagnostic of acute kidney injury, before volemic expansion.

Secondary Outcomes (3)

  • Tolerance of volemic expansion, as recommended by international guidelines

    After 48 hours of volemic expansion

  • Response to vasoconstrictor treatment of hepatorenal syndrome, in case of diagnostic of hepatorenal syndrome

    1 month after inclusion

  • Mortality

    1 month after inclusion

Study Arms (1)

cirrhosis with portal hypertension,ascite and acute kidney

OTHER
Procedure: Echocardiography

Interventions

cirrhosis with portal hypertension,ascite and acute kidney

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients \> 18 years
  • written consent for the participation of the study
  • cirrhosis with portal hypertension and ascite
  • acute kidney injury according to AKIN criteria (rapid increase of creatinine (48 hours) \> 26.4 µmol or \> 50% comparing with baseline). Baseline creatinine is the last value of creatinine before admission or creatinine at the admission if stable during 5 days.
  • absence of argument for acute tubular necrosis or other organic acute renal injury
  • absence of argument for shock

You may not qualify if:

  • pregnant women
  • volemic expansion before echocardiography
  • portal thrombosis
  • presence of TIPSS
  • history of cardiac or renal pathology
  • atrial fibrillation
  • cardiac valvulopathy
  • technical limitation due to echogenicity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon - Hôpital de la Croix-Rousse

Lyon, 69004, France

Location

MeSH Terms

Conditions

FibrosisHepatorenal SyndromeAcute Kidney Injury

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsLiver DiseasesDigestive System DiseasesKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesRenal Insufficiency

Study Officials

  • Fanny LEBOSSE, Dr

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2014

First Posted

March 27, 2014

Study Start

March 1, 2014

Primary Completion

July 1, 2018

Study Completion

July 1, 2018

Last Updated

December 19, 2025

Record last verified: 2025-12

Locations